Hotaling Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,675
Closed -$1.86M 118
2022
Q2
$1.86M Buy
20,675
+114
+0.6% +$11.6K 0.81% 36
2022
Q1
$2.28M Sell
20,561
-14,919
-42% -$1.58M 0.88% 37
2021
Q4
$3.67M Buy
35,480
+531
+2% +$61.5K 1.27% 19
2021
Q3
$4.38M Buy
34,949
+463
+1% +$59.9K 1.82% 11
2021
Q2
$4.28M Buy
34,486
+475
+1% +$59.6K 1.74% 11
2021
Q1
$4.02M Buy
34,011
+254
+0.8% +$29.8K 1.8% 14
2020
Q4
$3.95M Buy
33,757
+13,020
+63% +$1.43M 1.84% 14
2020
Q3
$2.15M Sell
20,737
-193
-0.9% -$19.4K 1.17% 29
2020
Q2
$1.92M Sell
20,930
-5,052
-19% -$484K 1.11% 28
2020
Q1
$2.34M Sell
25,982
-610
-2% -$64.9K 1.74% 17
2019
Q4
$3.02M Sell
26,592
-100
-0.4% -$11K 1.73% 16
2019
Q3
$2.9M Buy
26,692
+3,870
+17% +$404K 1.86% 13
2019
Q2
$2.22M Buy
22,822
+223
+1% +$20.4K 1.43% 20
2019
Q1
$2.06M Sell
22,599
-44
-0.2% -$3.94K 1.39% 22
2018
Q4
$2.06M Buy
+22,643
New +$2.12M 1.68% 18

Other funds holding MDT

Hotaling Investment Management's MDT Position: Q3 2022 in Review

Hotaling Investment Management sold out of Medtronic (MDT) in Q3 2022, closing a stake of 20,675 shares — an estimated $1.86M sold.

Hotaling Investment Management first reported a position in MDT in Q4 2018 and held it in 15 quarters. The position peaked at $4.38M in Q3 2021. 1,930 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Hotaling Investment Management reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Hotaling Investment Management sold 20,675 Medtronic shares in Q3 2022, an estimated $1.86M.
  • Hotaling Investment Management first reported a position in Medtronic in Q4 2018 and held it in 15 quarters.
  • Hotaling Investment Management's Medtronic position peaked at $4.38M in Q3 2021.
  • 1,930 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Hotaling Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.